Other genes confirmed to be expressed in TAMs with anti-tumor and favorably prognostic functions, CXCL9 (Bill et al., 2023) and CD169, were also enriched in bTAMs (Supplementary Figure S1H), further indicating the tumor suppressive properties of bM2-like TAMs. This evidence concerns the gene CXCL9 and neoplasm.